APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Tag: Coronavirus
APDN, Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
April 7th, 2021
An interview with Dr. James Hayward, Chairman, President & CEO
March 29th, 2021
APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits
March 11th, 2021
Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel
March 9th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021
APDN to Provide COVID-19 Surveillance Testing to LIM College
February 19th, 2021
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
February 11th, 2021
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 2nd, 2021